RCGP position statement on CYP2C19 genotyping implementation
The Royal College of General Practitioners have worked with stakeholders to produce a position statement to support prescribers who receive information that a patient has had CYP2C19 genotype testing.
Disclaimer
This is a resource you may find helpful to support implementation. It has not been produced by NICE and is not maintained by NICE. In the event of any issues or errors, please contact the RCGP.
This page was last updated: